Shares of Alibaba fell 4.0% to ARS 19,750 on September 23 as a wave of law-firm reminders about an approaching October 5 lead-plaintiff deadline amplified investor anxiety over a securities fraud lawsuit that strikes at the heart of the company's U.S. listing and AI ambitions. The selling mirrored a 4.36% drop in Hong Kong, signaling the pressure is global, not local.
• The Pentagon Put Alibaba on a Blacklist, and the Company Allegedly Saw It Coming. On June 8, 2026, the U.S. Department of Defense published an updated list of Chinese military companies that included Alibaba.
The lawsuit contends Alibaba was affiliated with China's MIIT through its telecommunications licensing requirements, yet its risk disclosures identified other Chinese companies delisted from the NYSE over military designations while omitting the company's own exposure. For shareholders, the designation could trigger forced selling by U.S. government pension funds and defense contractors barred from holding blacklisted securities.
• Anthropic Accused Alibaba of Stealing AI Capabilities on an Industrial Scale. Anthropic accused operators tied to Alibaba's AI lab of running 28.8 million conversations with Claude through roughly 25,000 fraudulent accounts between April 22 and June 5.
It is the largest extraction campaign Anthropic has ever reported, nearly double the one it pinned on three Chinese labs in February. If proven, these allegations could invite U.S. export or sanctions actions targeting Alibaba's cloud and AI divisions — the very businesses management has pitched as future growth engines.
• The Stock Has Already Been Cut Nearly in Half — and the Lawsuit Clock Is Still Ticking. BABA declined from a class-period high of $173.68 on October 9, 2025 to $95.07 on June 25, 2026 — a drop of approximately 45.26%.
Multiple law firms are blasting reminders about the October 5, 2026 lead-plaintiff deadline, which means the negative news cycle around BABA is unlikely to die down soon.
• The Real Risk Is Structural, Not Just Legal. The class action itself may or may not succeed — securities fraud suits against foreign issuers face high bars. But the underlying facts it rests on — a Pentagon blacklist and alleged mass IP theft — create regulatory overhang that could restrict Alibaba's access to U.S. capital markets, cloud partnerships, and chip supplies. BABA is no longer just an e-commerce and cloud story; it's now a live case study in how AI ethics, national-security policy, and disclosure rules collide. Until the legal and geopolitical fog clears, expect the stock to trade at a steep discount to its Chinese tech peers.